1. Home
  2. FLNT vs NXPLW Comparison

FLNT vs NXPLW Comparison

Compare FLNT & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLNT
  • NXPLW
  • Stock Information
  • Founded
  • FLNT 2010
  • NXPLW N/A
  • Country
  • FLNT United States
  • NXPLW United States
  • Employees
  • FLNT N/A
  • NXPLW 166
  • Industry
  • FLNT Advertising
  • NXPLW Telecommunications Equipment
  • Sector
  • FLNT Consumer Discretionary
  • NXPLW Telecommunications
  • Exchange
  • FLNT Nasdaq
  • NXPLW Nasdaq
  • Market Cap
  • FLNT N/A
  • NXPLW N/A
  • IPO Year
  • FLNT N/A
  • NXPLW N/A
  • Fundamental
  • Price
  • FLNT $2.20
  • NXPLW N/A
  • Analyst Decision
  • FLNT Hold
  • NXPLW
  • Analyst Count
  • FLNT 1
  • NXPLW 0
  • Target Price
  • FLNT $3.50
  • NXPLW N/A
  • AVG Volume (30 Days)
  • FLNT 11.3K
  • NXPLW 6.4K
  • Earning Date
  • FLNT 04-25-2025
  • NXPLW 03-31-2025
  • Dividend Yield
  • FLNT N/A
  • NXPLW N/A
  • EPS Growth
  • FLNT N/A
  • NXPLW N/A
  • EPS
  • FLNT N/A
  • NXPLW N/A
  • Revenue
  • FLNT $254,623,000.00
  • NXPLW $66,482,000.00
  • Revenue This Year
  • FLNT $9.20
  • NXPLW N/A
  • Revenue Next Year
  • FLNT $8.67
  • NXPLW N/A
  • P/E Ratio
  • FLNT N/A
  • NXPLW N/A
  • Revenue Growth
  • FLNT N/A
  • NXPLW 179.89
  • 52 Week Low
  • FLNT $2.01
  • NXPLW $0.25
  • 52 Week High
  • FLNT $4.30
  • NXPLW $0.26
  • Technical
  • Relative Strength Index (RSI)
  • FLNT 46.01
  • NXPLW N/A
  • Support Level
  • FLNT $2.07
  • NXPLW N/A
  • Resistance Level
  • FLNT $2.34
  • NXPLW N/A
  • Average True Range (ATR)
  • FLNT 0.18
  • NXPLW 0.00
  • MACD
  • FLNT 0.02
  • NXPLW 0.00
  • Stochastic Oscillator
  • FLNT 35.19
  • NXPLW 0.00

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: